Earnings · China A-shares
Chongqing Pharscin Pharmaceutical Co., Ltd. Class A (002907) earnings
Chongqing Pharscin Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit +39.67% year on year, +60.17% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -3.08% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- +39.67%
- Excl. one-offs YoY
- +60.17%
- Net profit QoQ
- +26.58%
- Result
- Good
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.30% | — |
| 3 days | -3.08% | — |
| 7 days | -3.45% | — |
| 14 days | -4.62% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 2 of 7 reports (average -0.91%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥101.20M | +39.67% | +60.17% | +3.70% | 0.24 | 5.84% | -3.08% | — | — |
| 2026 interim report | 2026-08-21 | ¥62.98M | +16.74% | +20.68% | -6.42% | 0.15 | 3.66% | +3.89% | +2.16% | +7.86% |
| 2026 Q1 report | 2026-04-30 | ¥32.79M | -18.74% | -22.92% | -11.34% | 0.08 | 1.92% | -2.30% | -14.29% | -16.34% |
| 2025 annual report | 2026-04-24 | ¥65.09M | -15.17% | -8.49% | +6.75% | 0.16 | 3.88% | +0.14% | -14.41% | -14.83% |
| 2025 Q3 report | 2025-10-29 | ¥72.46M | -2.84% | -13.03% | +1.90% | 0.17 | 4.31% | -0.91% | -6.48% | -3.01% |
| 2025 interim report | 2025-08-22 | ¥53.95M | +14.27% | +12.52% | +5.76% | 0.13 | 3.21% | -2.57% | -11.90% | -19.69% |
| 2025 Q1 report | 2025-04-25 | ¥40.36M | +0.01% | +1.08% | +4.62% | 0.10 | 2.40% | -1.55% | +26.39% | +23.15% |
| 2024 annual report | 2025-04-25 | ¥76.73M | +134.66% | +146.94% | +12.04% | 0.18 | 4.68% | -1.55% | +26.39% | +23.15% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.